Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Treasury Shares (2020 - 2025)

Mirum Pharmaceuticals has reported Treasury Shares over the past 6 years, most recently at $353743.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $353743.0 for Q4 2025, up 24.14% from a year ago — trailing twelve months through Dec 2025 was $353743.0 (up 24.14% YoY), and the annual figure for FY2025 was $353743.0, up 24.14%.
  • Treasury Shares for Q4 2025 was $353743.0 at Mirum Pharmaceuticals, roughly flat from $353743.0 in the prior quarter.
  • Over the last five years, Treasury Shares for MIRM hit a ceiling of $353743.0 in Q1 2025 and a floor of $22270.0 in Q3 2022.
  • Median Treasury Shares over the past 5 years was $222660.0 (2021), compared with a mean of $218862.3.
  • Biggest five-year swings in Treasury Shares: plummeted 85.71% in 2022 and later surged 120.92% in 2024.
  • Mirum Pharmaceuticals' Treasury Shares stood at $122464.0 in 2021, then tumbled by 81.82% to $22270.0 in 2022, then skyrocketed by 563.83% to $147835.0 in 2023, then soared by 92.75% to $284955.0 in 2024, then increased by 24.14% to $353743.0 in 2025.
  • The last three reported values for Treasury Shares were $353743.0 (Q4 2025), $353743.0 (Q3 2025), and $353743.0 (Q2 2025) per Business Quant data.